These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12061635)

  • 21. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the turkey herpesvirus vaccine by the aerogenic route for the prevention of Marek's disease.
    Eidson CS; Kleven SH
    Dev Biol Stand; 1976; 33():370-5. PubMed ID: 182596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of Efficacy and Replication of Recombinant Vector Vaccines by Using Turkey Herpesvirus Combined with Other Marek's Disease Vaccines.
    Gimeno IM; Cortes AL; Reilley A; Barbosa T; Alvarado I; Koopman R; Martinez A
    Avian Dis; 2019 Jun; 63(2):335-341. PubMed ID: 31251535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus.
    Sharma JM; Burmester BR
    Avian Dis; 1982; 26(1):134-49. PubMed ID: 6284106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious.
    Rahaus M; Augustinski K; Castells M; Desloges N
    Avian Dis; 2013 Jun; 57(2 Suppl):498-502. PubMed ID: 23901767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens.
    Esaki M; Noland L; Eddins T; Godoy A; Saeki S; Saitoh S; Yasuda A; Dorsey KM
    Avian Dis; 2013 Jun; 57(2):192-8. PubMed ID: 24689173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
    Geerligs H; Spijkers I; Rodenberg J
    Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field evaluations of safety and efficacy of an Australian Marek's disease vaccine.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2003 Apr; 81(4):222-5. PubMed ID: 15080446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response of chickens to serotype 1, 2, or 3 Marek's disease vaccines based on ELISA with infected cells as antigen.
    Mohammadi A; Spencer JL; Chan M; Ansari Lari M
    Avian Dis; 2007 Dec; 51(4):982-5. PubMed ID: 18251413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compatibility of turkey herpesvirus-infectious bursal disease vector vaccine with Marek's disease rispens vaccine injected into day-old pullets.
    Lemiere S; Wong SY; Saint-Gerand AL; Goutebroze S; Le Gros FX
    Avian Dis; 2011 Mar; 55(1):113-8. PubMed ID: 21500646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Various HVT Vaccines (Conventional and Recombinant) Against Marek's Disease in Broiler Chickens: Effect of Dose and Age of Vaccination.
    Gimeno IM; Cortes AL; Faiz N; Villalobos T; Badillo H; Barbosa T
    Avian Dis; 2016 Sep; 60(3):662-8. PubMed ID: 27610727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses.
    Tan J; Cooke J; Clarke N; Tannock GA
    Avian Pathol; 2007 Oct; 36(5):351-9. PubMed ID: 17899458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
    Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
    Reddy SM; Izumiya Y; Lupiani B
    Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.